Ishares Msci Brazil ETF vs 22nd Century Group Inc — how do they compare? Ishares Msci Brazil ETF trades at $43.4 (market cap $11.30B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Ishares Msci Brazil ETF is far larger — about 18176.8× 22nd Century Group Inc's market cap, and Ishares Msci Brazil ETF is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ishares Msci Brazil ETF for 50 Days and 22nd Century Group Inc for 32 Days on average.
| EWZ | XXII | |
|---|---|---|
Market Cap | $11.30B | $621.67K |
Volume | 44,036,597 | 45,625 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $43.00 | $483.00 |
52-Week Low | $28.79 | $0.80 |
Typical Hold Time | 50 Days | 32 Days |
Enterprise Value | — | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
EWZ, the iShares MSCI Brazil ETF, is trading at $43.54, up 2.76% today, with strong bullish momentum from moving averages but overbought RSI signals. The ETF is positioned as a diversification play against U.S. tech concentration, benefiting from Brazil's commodity exposure and election-driven optimism. Recent unusual options activity and institutional buying reflect heightened investor interest ahead of October's presidential election.
The outlook hinges on Brazil's election outcome and commodity trends, offering asymmetric upside via call spreads. Risks include political volatility, U.S. tariff impacts, and competition from lower-fee Brazil ETFs like FLBR. Wall Street sentiment is cautiously optimistic, with the trade acting as a hedge against AI-driven U.S. market risks.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →